Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. A. Verniuk"'
Autor:
A. M. Chervontseva, M. A. Verniuk, E. E. Gushchina, I. V. Cherkashina, O. A. Pavlova, L. S. Khayrullina, А. А. Fedenko
Publikováno v:
Онкогематология, Vol 16, Iss 2, Pp 28-39 (2021)
Objective. Comparative evaluation of the effectiveness and toxicity profile of intensified chemotherapy regimens BEACOPP escalated (esc.), BEACOPP-14 and EACOPP‑14 in primary patients with classical Hodgkin’s lymphoma of an unfavorable prognostic
Externí odkaz:
https://doaj.org/article/5c99b72af2204ac2ae861d21611ba6f9
Publikováno v:
Сибирский онкологический журнал, Vol 20, Iss 1, Pp 155-161 (2021)
Background. The use of modern induction chemotherapy programs for primary Hodgkin’s lymphoma allows achievement of high long-term outcomes even in patients with initially poor prognosis. However, the toxicity of treatment is quite high. Despite the
Externí odkaz:
https://doaj.org/article/5c10bbf49ac941cf93354649c270b0f9
Autor:
E N, Parovichnikova, V G, Savchenko, M A, Verniuk, O A, Vinogradova, A V, Misiurin, I A, Vorob'ev, E V, Domracheva, L Iu, Tikhonova, O A, Rukavitsyn, V A, Rossiev, G A, Kliasova, A G, Turkina, L S, Liubimova, L P, Mendeleeva, V G, Isaev
Publikováno v:
Terapevticheskii arkhiv. 77(7)
To develop an original therapeutic strategy in Ph-positive acute lymphoblastic leukemia (ALL).In November 2001 Hematological Research Center (HRC) initiated the study of chimeric BCR-ABL gene. During the first stage of the study (November 2001-July 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2c4bb3cd5c3b5bbf5212ed1704d09f6
https://pubmed.ncbi.nlm.nih.gov/16116902
https://pubmed.ncbi.nlm.nih.gov/16116902